2,019
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Why are sodium channel modulators not yet pharmacotherapeutic trailblazers for neuropathic pain?

Pages 1635-1637 | Received 23 Nov 2020, Accepted 12 Apr 2021, Published online: 26 Apr 2021
 

Declaration of interest

The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

The author’s research was funded by the Wellcome Trust Pain Consortium, 102645: ‘Defining Pain Circuitry in Health and Disease’.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.